⌘K
Latigo Biotherapeutics
Healthcare & Life Sciences
Recent Finacing
Series B
Recent Raise
$150M
Latigo Biotherapeutics develops non-opioid pain treatments, focusing on selective Nav1.8 inhibitors.
Focus Areas
Non-opioid
pain treatments
Nav1.8 inhibitors
drug development
biotherapeutics
Investors
